N6-Benzoyladenosine: A Potent Anti-Tumor Agent with Broad Pharmaceutical Research Applications
Discover the advanced potential of N6-Benzoyladenosine in oncology and biochemical research.
Get a Quote & SampleProduct Core Value
N6-Benzoyladenosine
N6-Benzoyladenosine, identified by its CAS number 4546-55-8, is a significant purine nucleoside derivative celebrated for its potent anti-tumor capabilities. Its molecular structure, enhanced with a benzoyl modification, significantly boosts its stability and resistance to phosphorylation, which distinguishes it from other nucleosides and improves its bioavailability. This makes it a vital compound in pharmaceutical development, particularly in targeting cancer cells and understanding complex cellular processes. Researchers globally seek this compound for its reliable high purity (≥99.0%) and its established role in exploring novel therapeutic avenues.
- Leveraging N6-Benzoyladenosine anti-tumor agent properties can lead to breakthroughs in cancer therapy research.
- The CAS 4546-55-8 pharmaceutical research applications are extensive, aiding in the discovery of new treatments.
- Investigating purine nucleoside derivative stability is key to developing more effective drugs.
- N6-Benzoyladenosine's role in adenosine receptor modulation opens new doors for neurobiological and oncological studies.
Key Advantages
Enhanced Therapeutic Efficacy
The unique benzoyl modification of N6-Benzoyladenosine significantly enhances its stability and bioavailability, making it a more effective agent for cancer therapy research and other critical applications.
High Purity and Reliability
With an assay of ≥99.0% via HPLC, researchers can depend on N6-Benzoyladenosine for consistent and accurate results in their biochemical research and drug discovery endeavors.
Versatile Research Applications
This compound is instrumental in exploring adenosine receptor modulation, proving valuable in both neurobiological studies and advancing cancer therapy research.
Key Applications
Oncology Research
As a potent anti-tumor agent, N6-Benzoyladenosine is vital for developing new cancer treatments and understanding the mechanisms of cancer cell growth.
Pharmaceutical Development
Its role in modulating cellular signaling pathways and its inherent stability make it a crucial intermediate for synthesizing novel pharmaceutical compounds.
Biochemical Studies
N6-Benzoyladenosine is a key tool for investigating adenosine receptors and their functions in various biological systems, aiding broad biochemical research.
Neuroscience Research
The compound shows promise in studying neurodegenerative diseases by influencing metabolic regulation and cellular energy production pathways.